Which has preferable earnings and valuation, ALVOW or APLMW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alvotech $491.95M N/A N/A N/A N/A Apollomics $8.50M N/A N/A N/A N/A

Is ALVOW or APLMW more profitable?

Company Net Margins Return on Equity Return on Assets Alvotech N/A N/A N/A Apollomics N/A N/A N/A

Which has preferable valuation and earnings, ARAV or ALVOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Aravive N/A N/A N/A -$0.90 N/A Alvotech $491.95M N/A N/A N/A N/A

Is ARAV or ALVOW more profitable?

Company Net Margins Return on Equity Return on Assets Aravive N/A N/A N/A Alvotech N/A N/A N/A

Which has preferable valuation and earnings, BIAFW or ALVOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio bioAffinity Technologies $5.85M N/A N/A N/A N/A Alvotech $491.95M N/A N/A N/A N/A

Is BIAFW or ALVOW more profitable?

Company Net Margins Return on Equity Return on Assets bioAffinity Technologies N/A N/A N/A Alvotech N/A N/A N/A

Which has better earnings and valuation, BIVIW or ALVOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio BioVie N/A N/A N/A N/A N/A Alvotech $491.95M N/A N/A N/A N/A

Is BIVIW or ALVOW more profitable?

Company Net Margins Return on Equity Return on Assets BioVie N/A N/A N/A Alvotech N/A N/A N/A

Which has higher valuation and earnings, ALVOW or CDIOW?

Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alvotech $491.95M N/A N/A N/A N/A Cardio Diagnostics $14.45K N/A N/A N/A N/A

Is ALVOW or CDIOW more profitable?

Company Net Margins Return on Equity Return on Assets Alvotech N/A N/A N/A Cardio Diagnostics N/A N/A N/A

Alvotech (ALVOW) Competitors

$0.26 0.00 (-1.78%)

As of 10/2/2026 12:37 PM Eastern

Compare

ALVOW vs. APLMW, ARAV, BIAFW, BIVIW, and CDIOW

Should you buy Alvotech stock or one of its competitors? Alvotech's main competitors and comparable companies include Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Alvotech compare to Apollomics?

Alvotech (NASDAQ:ALVOW) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, valuation, risk, earnings, media sentiment, institutional ownership and dividends.

In the previous week, Alvotech's average media sentiment score of 0.00 equaled Apollomics'average media sentiment score.

Company	Overall Sentiment
Alvotech	Neutral
Apollomics	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$491.95M	N/A	N/A	N/A	N/A
Apollomics	$8.50M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
Apollomics	N/A	N/A	N/A

Summary

Alvotech beats Apollomics on 1 of the 1 factors compared between the two stocks.

How does Alvotech compare to Aravive?

Aravive (NASDAQ:ARAV) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, profitability, dividends, media sentiment, risk, analyst recommendations, earnings and institutional ownership.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Aravive	N/A	N/A	N/A	-$0.90	N/A
Alvotech	$491.95M	N/A	N/A	N/A	N/A

In the previous week, Aravive's average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score.

Company	Overall Sentiment
Aravive	Neutral
Alvotech	Neutral

Company	Net Margins	Return on Equity	Return on Assets
Aravive	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Aravive beats Alvotech on 2 of the 3 factors compared between the two stocks.

How does Alvotech compare to bioAffinity Technologies?

bioAffinity Technologies (NASDAQ:BIAFW) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, media sentiment, analyst recommendations and risk.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
bioAffinity Technologies	$5.85M	N/A	N/A	N/A	N/A
Alvotech	$491.95M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
bioAffinity Technologies	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

In the previous week, bioAffinity Technologies had 1 more articles in the media than Alvotech. MarketBeat recorded 1 mentions for bioAffinity Technologies and 0 mentions for Alvotech. Alvotech's average media sentiment score of 0.00 beat bioAffinity Technologies' score of -0.78 indicating that Alvotech is being referred to more favorably in the news media.

Company	Overall Sentiment
bioAffinity Technologies	Negative
Alvotech	Neutral

Summary

Alvotech beats bioAffinity Technologies on 2 of the 3 factors compared between the two stocks.

How does Alvotech compare to BioVie?

BioVie (NASDAQ:BIVIW) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, valuation, earnings, analyst recommendations, risk, institutional ownership, media sentiment and dividends.

In the previous week, BioVie's average media sentiment score of 0.00 equaled Alvotech'saverage media sentiment score.

Company	Overall Sentiment
BioVie	Neutral
Alvotech	Neutral

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
BioVie	N/A	N/A	N/A	N/A	N/A
Alvotech	$491.95M	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
BioVie	N/A	N/A	N/A
Alvotech	N/A	N/A	N/A

Summary

Alvotech beats BioVie on 1 of the 1 factors compared between the two stocks.

How does Alvotech compare to Cardio Diagnostics?

Alvotech (NASDAQ:ALVOW) and Cardio Diagnostics (NASDAQ:CDIOW) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, institutional ownership, earnings, media sentiment, analyst recommendations, risk, dividends and valuation.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alvotech	$491.95M	N/A	N/A	N/A	N/A
Cardio Diagnostics	$14.45K	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
Alvotech	N/A	N/A	N/A
Cardio Diagnostics	N/A	N/A	N/A

In the previous week, Alvotech's average media sentiment score of 0.00 equaled Cardio Diagnostics'average media sentiment score.

Company	Overall Sentiment
Alvotech	Neutral
Cardio Diagnostics	Neutral

Summary

Alvotech beats Cardio Diagnostics on 1 of the 1 factors compared between the two stocks.

Get Alvotech News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALVOW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ALVOW vs. The Competition

Export

Metric	Alvotech	Biotechnology Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	N/A	$3.86B	$7.16B	$13.28B
Dividend Yield	N/A	3.65%	2.54%	17.32%
P/E Ratio	N/A	13.06	275.66	26.04
Price / Sales	N/A	1,295.79	609.46	91.89
Price / Cash	N/A	123.39	78.87	52.62
Price / Book	N/A	16.63	10.93	6.31
Net Income	N/A	-$22.71M	$3.51B	$362.16M
7 Day Performance	-29.73%	-2.99%	-2.00%	-1.66%
1 Month Performance	-18.75%	-10.60%	-6.15%	-4.50%
1 Year Performance	-82.52%	19.44%	7.44%	2.06%

Alvotech Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ALVOW Alvotech	N/A	$0.26 -1.8%	N/A	-80.6%	$0.00	$491.95M	N/A	4	Positive News
APLMW Apollomics	N/A	$0.01 flat	N/A	-45.0%	$0.00	$8.50M	N/A	15	Positive News Gap Up
ARAV Aravive	N/A	$0.04 flat	N/A	N/A	$0.00	N/A	N/A	20	High Trading Volume
BIAFW bioAffinity Technologies	N/A	$0.28 -12.5%	N/A	+2.0%	$0.00	$5.85M	N/A	10	News Coverage Gap Up
BIVIW BioVie	N/A	$0.29 -5.0%	N/A	N/A	$0.00	N/A	N/A	N/A	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ALVOW) was last updated on 10/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alvotech (ALVOW) Competitors